DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,003,000 | -55.2% | 49,739 | -17.1% | 0.00% | -50.0% |
Q2 2021 | $2,240,000 | +47.3% | 60,024 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $1,521,000 | +16.0% | 59,500 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $1,311,000 | +22.5% | 59,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,070,000 | -29.2% | 59,500 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $1,511,000 | +76.9% | 59,500 | +28.0% | 0.00% | +100.0% |
Q1 2020 | $854,000 | -16.6% | 46,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,024,000 | +32.3% | 46,500 | -13.7% | 0.00% | 0.0% |
Q3 2019 | $774,000 | -8.8% | 53,900 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $849,000 | +7.5% | 53,900 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $790,000 | +74.4% | 53,900 | +27.1% | 0.00% | 0.0% |
Q4 2018 | $453,000 | -39.9% | 42,400 | -14.2% | 0.00% | 0.0% |
Q3 2018 | $754,000 | +24.6% | 49,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $605,000 | +717.6% | 49,400 | +258.0% | 0.00% | – |
Q1 2016 | $74,000 | -54.9% | 13,800 | 0.0% | 0.00% | – |
Q4 2015 | $164,000 | +45.1% | 13,800 | 0.0% | 0.00% | – |
Q3 2015 | $113,000 | -27.1% | 13,800 | +24.4% | 0.00% | – |
Q2 2015 | $155,000 | – | 11,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 2,456,595 | $49,525,000 | 9.00% |
COMMODORE CAPITAL LP | 1,292,251 | $26,052,000 | 6.87% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $62,098,000 | 3.85% |
GREAT POINT PARTNERS LLC | 799,999 | $16,128,000 | 3.76% |
DAFNA Capital Management LLC | 587,456 | $11,843,000 | 3.14% |
Eagle Health Investments LP | 406,525 | $8,196,000 | 2.60% |
RTW INVESTMENTS, LP | 7,582,396 | $152,861,000 | 2.30% |
Parkman Healthcare Partners LLC | 209,686 | $4,227,000 | 1.07% |
Palo Alto Investors LP | 855,713 | $17,251,000 | 1.04% |
Lombard Odier Asset Management (Switzerland) SA | 701,305 | $14,138,000 | 0.88% |